gallium ga-68 edotreotide · Uihc Pet Imaging · NDA 210828
Gallium Ga 68 Edotreotide
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026First generic approved · 210828-00110 Oct 2025
- 25 Oct 2026Generic approved · 210828-00110 Oct 2025
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210828 · 001 · RLD | solution, intravenous | 0.5-4mCi/ML | open |
Expired or delisted (2)
- ODE-383 · 21 Aug 2026
- W · 21 Aug 2026